These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16231753)

  • 1. Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis.
    Kai H; Kuwahara F; Tokuda K; Imaizumi T
    Hypertens Res; 2005 Jun; 28(6):483-90. PubMed ID: 16231753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal women.
    Mori T; Kai H; Kajimoto H; Koga M; Kudo H; Takayama N; Yasuoka S; Anegawa T; Kai M; Imaizumi T
    Hypertens Res; 2011 Apr; 34(4):496-502. PubMed ID: 21248760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?
    Kuwahara F; Kai H; Tokuda K; Takeya M; Takeshita A; Egashira K; Imaizumi T
    Hypertension; 2004 Apr; 43(4):739-45. PubMed ID: 14967845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
    Tokuda K; Kai H; Kuwahara F; Yasukawa H; Tahara N; Kudo H; Takemiya K; Koga M; Yamamoto T; Imaizumi T
    Hypertension; 2004 Feb; 43(2):499-503. PubMed ID: 14699000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats.
    Matsubara LS; Matsubara BB; Okoshi MP; Franco M; Cicogna AC
    Can J Physiol Pharmacol; 1997 Dec; 75(12):1328-34. PubMed ID: 9534942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats.
    Kuwahara F; Kai H; Tokuda K; Kai M; Takeshita A; Egashira K; Imaizumi T
    Circulation; 2002 Jul; 106(1):130-5. PubMed ID: 12093782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
    Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
    J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced coronary vascular turgor effect on post-ischemic diastolic function in hypertrophied hearts.
    Yamamoto H; Yamamoto F; Ichikawa H
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):605-8. PubMed ID: 19589788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling.
    Kuwahara F; Kai H; Tokuda K; Niiyama H; Tahara N; Kusaba K; Takemiya K; Jalalidin A; Koga M; Nagata T; Shibata R; Imaizumi T
    Hypertension; 2003 Mar; 41(3 Pt 2):819-23. PubMed ID: 12624002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II.
    Kai H; Mori T; Tokuda K; Takayama N; Tahara N; Takemiya K; Kudo H; Sugi Y; Fukui D; Yasukawa H; Kuwahara F; Imaizumi T
    Hypertens Res; 2006 Sep; 29(9):711-8. PubMed ID: 17249527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
    Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
    Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeletal remodeling of desmin is a more accurate measure of cardiac dysfunction than fibrosis or myocyte hypertrophy.
    Monreal G; Nicholson LM; Han B; Joshi MS; Phillips AB; Wold LE; Bauer JA; Gerhardt MA
    Life Sci; 2008 Dec; 83(23-24):786-94. PubMed ID: 18955067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
    Sciarretta S; Paneni F; Palano F; Chin D; Tocci G; Rubattu S; Volpe M
    Clin Sci (Lond); 2009 Mar; 116(6):467-77. PubMed ID: 19200056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial interstitial fibrosis and diastolic dysfunction in hypertrophic cardiomyopathy].
    Lombardi R; Betocchi S; Cacace A; Losi MA; Chiariello M
    Ital Heart J Suppl; 2003 Aug; 4(8):645-50. PubMed ID: 14655460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
    Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.